ATE387507T1 - Screeningverfahren für die oligonukleotidtransfektion - Google Patents

Screeningverfahren für die oligonukleotidtransfektion

Info

Publication number
ATE387507T1
ATE387507T1 AT01992188T AT01992188T ATE387507T1 AT E387507 T1 ATE387507 T1 AT E387507T1 AT 01992188 T AT01992188 T AT 01992188T AT 01992188 T AT01992188 T AT 01992188T AT E387507 T1 ATE387507 T1 AT E387507T1
Authority
AT
Austria
Prior art keywords
peptoids
screening method
oligonucleotide transfection
transfection
screening
Prior art date
Application number
AT01992188T
Other languages
English (en)
Inventor
Ronald Zuckermann
Christoph Reinhard
Ann Jefferson
Eric Beausoleil
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of ATE387507T1 publication Critical patent/ATE387507T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials
AT01992188T 2000-12-23 2001-12-18 Screeningverfahren für die oligonukleotidtransfektion ATE387507T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25797500P 2000-12-23 2000-12-23
US32918501P 2001-10-11 2001-10-11

Publications (1)

Publication Number Publication Date
ATE387507T1 true ATE387507T1 (de) 2008-03-15

Family

ID=26946324

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01992188T ATE387507T1 (de) 2000-12-23 2001-12-18 Screeningverfahren für die oligonukleotidtransfektion

Country Status (9)

Country Link
US (1) US7422861B2 (de)
EP (1) EP1404867B1 (de)
JP (2) JP2005502309A (de)
AT (1) ATE387507T1 (de)
CA (1) CA2431219C (de)
DE (1) DE60133049T2 (de)
ES (1) ES2300379T3 (de)
PT (1) PT1404867E (de)
WO (1) WO2002052046A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783929B1 (en) * 1999-11-02 2004-08-31 Chiron Corporation Biological sample component purification and differential display
US7026166B2 (en) * 2002-01-22 2006-04-11 Chiron Corporation Fluorogenic dyes
US7704756B2 (en) * 2003-01-21 2010-04-27 Novartis Vaccines And Diagnostics, Inc. Fluorogenic dyes
AU2004305111B2 (en) * 2003-12-19 2011-04-28 Novartis Vaccines And Diagnostics, Inc. Cell transfecting formulations of small interfering RNA, related compositions and methods of making and use
NZ594844A (en) * 2005-09-09 2013-04-26 Novartis Ag Prion-specific peptoid reagents
WO2010017412A1 (en) 2008-08-06 2010-02-11 The Regents Of The University Of California Novel biomimetic peptoid polymers
JP2016528510A (ja) 2013-08-21 2016-09-15 ミカルティス エヌブイＭｙｃａｒｔｉｓ Ｎｖ 不均質表面官能化
AU2016338410B2 (en) 2015-10-14 2021-07-15 X-Therma, Inc. Compositions and methods for reducing ice crystal formation
AU2022323376A1 (en) * 2021-08-06 2024-02-22 Nutcracker Therapeutics, Inc. Compositions comprising hydroxyethyl-capped cationic peptoids
NL2029057B1 (en) * 2021-08-06 2023-02-21 Nutcracker Therapeutics Inc Compositions comprising hydroxyethyl-capped cationic peptoids

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE66205B1 (en) 1990-06-14 1995-12-13 Paul A Bartlett Polypeptide analogs
US5650489A (en) * 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
US5264419A (en) 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives
WO1994002515A1 (en) * 1992-07-21 1994-02-03 Bunsen Rush Laboratories Inc. Oligomer library formats and methods relating thereto
US5877278A (en) * 1992-09-24 1999-03-02 Chiron Corporation Synthesis of N-substituted oligomers
EP0671928B1 (de) 1992-09-24 2002-11-27 Chiron Corporation Synthese von N-substituierten Oligomeren
JPH08504444A (ja) 1992-12-11 1996-05-14 カイロン コーポレイション コードされるポリマーの合成
IL106106A0 (en) 1993-06-22 1993-10-20 Interpharm Lab Ltd Library of polymeric molecules and its preparation
GB2295152A (en) 1994-11-18 1996-05-22 Pfizer Ltd Preparation of a library of compounds by solid-phase synthesis
US5481020A (en) * 1994-12-30 1996-01-02 Chiron Corporation Opiate receptor ligands
US5958792A (en) 1995-06-07 1999-09-28 Chiron Corporation Combinatorial libraries of substrate-bound cyclic organic compounds
US5935936A (en) * 1996-06-03 1999-08-10 Genzyme Corporation Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
CA2264012C (en) 1996-08-13 2011-04-26 Chiron Corporation Compositions and methods for polynucleotide delivery
JP2002515044A (ja) * 1996-08-21 2002-05-21 スミスクライン・ビーチャム・コーポレイション ビーズ−ベースのコンビナトリアルライブラリーを配列し合成する迅速方法
WO1998010857A1 (en) 1996-09-12 1998-03-19 Chiron Corporation Actuation means for use in solid phase chemical synthesis involving arrays of modular reaction vessels
EP0934113B1 (de) 1996-10-22 2002-04-03 Chiron Corporation Umkehrfiltrationsvorrichtung sowie anwendungsverfahren
WO1998027209A1 (en) * 1996-12-18 1998-06-25 Emory University Polycationic oligomers
ATE437887T1 (de) 1997-04-28 2009-08-15 Novartis Vaccines & Diagnostic Vorrichtung zur herstellung von oligomeren, insbesondere peptoiden, mit rückführung der reagenzien
US6197332B1 (en) 1997-08-13 2001-03-06 Chiron Corporation Lipid-conjugated polyamide compounds and related compositions and methods thereof
JP2002514743A (ja) 1998-05-08 2002-05-21 カイロン コーポレイション 非合成的デコンボルーションのための方法およびデバイス
PT1144609E (pt) 1999-08-27 2008-05-28 Novartis Vaccines & Diagnostic Oligonucleótidos anti-sentido quiméricos e suas formulações para transfecção de células

Also Published As

Publication number Publication date
WO2002052046A2 (en) 2002-07-04
US20020151062A1 (en) 2002-10-17
EP1404867A2 (de) 2004-04-07
JP2008086318A (ja) 2008-04-17
CA2431219A1 (en) 2002-07-04
DE60133049T2 (de) 2009-02-19
PT1404867E (pt) 2008-06-05
US7422861B2 (en) 2008-09-09
WO2002052046A3 (en) 2004-02-12
EP1404867B1 (de) 2008-02-27
CA2431219C (en) 2012-02-07
ES2300379T3 (es) 2008-06-16
JP2005502309A (ja) 2005-01-27
DE60133049D1 (de) 2008-04-10
JP4611357B2 (ja) 2011-01-12

Similar Documents

Publication Publication Date Title
ATE387507T1 (de) Screeningverfahren für die oligonukleotidtransfektion
EP1590476A4 (de) Proteinfragment komplementationstests zum screening mit hohem durchsatz und hohem gehalt
ATE516497T1 (de) Screening für funktionshomologien
DE69824586D1 (de) Probenträger hoher dichte für die analyse biologischer proben
ATE470722T1 (de) Strategien zur genexpressionsanalyse
ATE408455T1 (de) Arrayplatten und verfahren zur herstellung von arrayplatten
CY1108634T1 (el) Μεθοδος και συσκευη για την προετοιμασια δειγματων ιστου για παραλληλη αναλυση
WO2002010750A3 (en) Biosensors, reagents and diagnostic applications of directed evolution
GB2308692B (en) A forecasting control system and method
DE50111819D1 (de) Verwendung einer mikrobiologischen kultur für die einleitung von mikrobiologischen abläufen in der aquaristik
ATE409236T1 (de) Derivatisierte nukleinsäuren und deren verwendung
DE69937024D1 (de) Verfahren für die Methangärung von organischen Abfällen
NZ597400A (en) Methods and Materials Using Signaling Probes
NO20053244D0 (no) Katalytisk reaktor og fremgangsmate.
NO20006384L (no) Kombinatorisk reaktor for katalytiske reaksjoner
DE602005023710D1 (de) Dna-array zur analyse der dna-methylierung, konstruktionsverfahren dafür sowie verfahren zur analyse der dna-methylierung
ATE525128T1 (de) Selektive methanizierung von kohlenmonoxide in einem wasserstoffreichen brennstoff
IL166238A0 (en) Functional screening method
Jost et al. A polymer physics view on universal and sequence-specific aspects of chromosome folding
NO994873D0 (no) Metode for syntese og analyse av kombinatoriske kjemibiblioteker
DE60331686D1 (de) Mikroarray-vorrichtungen mit steuerbarem reaktionsvolumen
EP3797171A1 (de) Einzelzellkartierung und transkriptomanalyse
DE60221550D1 (de) Methode zur bestimmung der zellzyklusposition
DE60333101D1 (de) Ierten organismen
EP1268842A4 (de) Verbessertes verfahren für reverses n-hybrid-screening

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1404867

Country of ref document: EP